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Summary
Objective: To determine if the biosynthesis of aggrecan and decorin in the human meniscus and the potential of the cells to express these
macromolecules (mRNA), is affected by the age of the individual and that if any changes are observed are they different to those measured
in articular cartilage obtained from the same joint.
Design: Radiolabelling of tissue explants, anion-exchange chromatography and agarose-polyacrylamide gel electrophoresis were used to
analyze newly synthesized proteoglycans. A quantitative, competitive reverse-transcriptase polymerase chain reaction was developed and
applied to the tissue to measure the expression of decorin and aggrecan mRNA.
Results: Proteoglycan synthesis in the meniscus was higher in young donors (1–5 mmoles sulfate incorporated/h/mgDNA, under 20 years
of age) than in adult tissues (0.5–1 mmoles incorporated/h/mgDNA, 20–62 years of age) and decorin was the major proteoglycan
synthesized at this time. An age-related increase in the proportion of aggrecan synthesis in the meniscus was also observed using
agarose-polyacrylamide gel electrophoresis. Both decorin (five-fold) and aggrecan (eight-fold) mRNA expression increased with age in
meniscus whereas levels were relatively constant in articular cartilage. In addition, the synthesis of decorin and aggrecan and the expression
of their mRNA was different in meniscus and articular cartilage from the same knee joint.
Conclusion: The synthesis and turnover of aggrecan and decorin in the human meniscus is influenced by the age of the individual and is not
the same as that observed for articular cartilage. © 2001 OsteoArthritis Research Society International
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The menisci are the largest non-articular tissues in the
knee joint and, as such, they contribute significantly to the
composition of the synovial fluid by releasing a large
proportion of their turnover products, some of which may be
tissue-specific. Very little is known about the composition
and metabolism of the extracellular matrix of the human
meniscus. Two morphologically distinct populations of cells
(fibrochondrocytes) have been identified. Fibroblastic-like
cells are present in the superficial zone (closest to the
surface of the meniscus), whereas chondrocytic-like cells
are found in the deeper, avascular region of the tissue.1,2
The meniscus has been defined as a fibrocartilaginous
structure, mainly on the basis of its content of type I
collagen,3 but small amounts of other collagens have also
been identified in the tissue4–7 as well as non-collagenous
matrix proteins such as link protein.8 We have also shown
that a wide range of non-collagenous matrix proteins
are present in the human meniscus (manuscript in33preparation). These include cartilage oligomeric matrix pro-
tein (COMP),9 fibronectin10 and cartilage intermediate layer
protein (CILP).11 The concentration of these proteins have
also been measured in aging and osteoarthritic articular
cartilage.11–13
There have been several reports concerning the proteo-
glycan composition of the human meniscus. High molecu-
lar weight ‘aggrecan-like’ molecules were identified in one
study14 and in a subsequent investigation it was shown that
this proteoglycan could bind to hyaluronic acid.15 Aggrecan
from meniscus was also found to contain mainly 4-sulfated
chondroitin sulfate chains and to possess more of them
relative to keratan sulfate chains, than articular cartilage of
the same age. This composition was recognized as being
more akin to that of aggrecan from immature articular
cartilage.16
Analysis of the low molecular weight proteoglycans,
decorin and biglycan, showed that decorin is the dominant,
endogenous, non-aggregating proteoglycan in the adult
meniscus.17 Decorin was also found to be the major low
molecular weight PG in adult human articular cartilage,18
but in immature articular cartilage biglycan was present at
much higher concentrations than decorin.19 Furthermore,
age-related changes in the composition and structure of
collagens, proteoglycans, glycosaminoglycan chains and
non-collagenous proteins have been reported in humanReceived 15 November 1999; accepted 12 May 2000.
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SOURCE OF TISSUE
Human menisci and articular cartilage specimens were
obtained within 2–3 h of operation from the knee joints of
donors who were undergoing surgery for bone tumors in
the femur or tibia. The tissue was macroscopically normal
and the tumor did not involve the joint space. A histological
analysis of each meniscus and cartilage sample was car-
ried out and although the older specimens did show some
signs of matrix disorganization, it was not possible to say
with any certainty that these were pathological in origin.
Menisci were dissected free of ligamentous attachments
and sliced into triangular-shaped explants of approximately
equal size. Lateral and medial menisci from the same knee
joint were always analyzed separately. Full thickness
articular cartilage was also removed from the femoral
condyle and diced into approximately 1 mm3 pieces.PROTEOGLYCAN SYNTHESIS
Triplicate slices (1–2 mm thick) of meniscus explants
and of full-depth samples of articular cartilage from donors
aged 11–61 years were pulse-labeled for 4 h in 1 ml
Dulbecco’s modified Eagles medium containing 50 Ci/ml
[35S]-sulfate (Amersham, Bucks, U.K.) at 37°C. Tissue
was dried to a constant weight and digested with papain
(Boehringer Mannheim, Sussex, U.K.). An alcian blue pre-
cipitation method23 was used to determine the extent of
incorporation of [35S]-sulfate into glycosaminoglycan
chains. Rates of [35S]-sulfate incorporation were deter-
mined using the calculation described by Maroudas24 and
were expressed as nmols [35S]-sulfate incorporated/h/mg
DNA content of tissue.MONO Q ANION-EXCHANGE CHROMATOGRAPHY
Newly synthesized proteoglycans in the meniscus from
the same tissue age range as noted above (11–61 years)were analyzed further by anion-exchange chromatography.
Articular cartilage specimens from the 17–61-year-old
donors were also available for these studies. Slices of
meniscus or cartilage explants (approximately 400 mg wet
weight) were radiolabeled for 5 h in Ham’s F12 medium
(a low [SO4]2− containing medium) supplemented with
100 Ci/ml [3H]-leucine and 50 Ci/ml [35S]-sulfate. Tissue
was cryosectioned at 20 m and matrix macromolecules
were extracted with 4 M guanidine hydrochloride.25
Extracts were separated from tissue residues by filtration
through a fibreglass filter and non-incorporated isotopes in
the tissue extracts were separated from radiolabeled
proteins on PD-10 columns packed with Sephadex G50
(Pharmacia Biotech, Uppsala, Sweden; 1.5 cm×5 cm).
Aliquots of tissue extracts corresponding to 5×105 dpm of
incorporated [3H]-leucine were dialyzed into 7 M urea,
20 mM Tris, pH 8.0 and then fractionated on a 1 ml
anion-exchange monoQ HPLC column (Pharmacia
Biotech, Uppsala, Sweden). Matrix proteins were separ-
ated from proteoglycans using a salt gradient (15 ml)
ranging in concentration from 0–1 M NaCl. Thirty fractions
of 1 ml were collected at a flow rate of 0.5 ml/min and an
aliquot from each (30 l) was monitored for radioactivity by
liquid scintillation counting.AGAROSE-POLYACRYLAMIDE GEL ELECTROPHORESIS
Aliquots of the mono Q fractions (400 l) containing
radiolabeled PG (fractions 21–24) were electrophoresed
in agarose-polyacrylamide gels under denaturing con-
ditions26 and proteoglycans were localized by staining
the gel with toluidine blue. Gels were dried on gel-bond
membrane (Pharmacia Biotech, Uppsala, Sweden) and
exposed to Kodak Biomax imaging film (Amersham). Gels
were also Western blotted, i.e. proteoglycans were trans-
ferred onto Hybond N+ nylon membrane (Amersham) and
probed with polyclonal antibodies which recognized (1) the
G1 domain of human aggrecan,27 (2) human decorin or (3)
human biglycan (LF-15). Anti-human decorin was a gift of
Dr Pilar Lorenzo, University of Lund, Sweden. LF-15 was a
gift of Dr L Fisher (NIH, Maryland, U.S.A.).EXTRACTION OF RNA
Samples of meniscus from knee joints of donors aged
8–88 years and articular cartilage from the same knee
joints up to and including the 71-year-old donor were used
for RNA extraction. Tissue from some of these samples
were also used for the biosynthetic studies described
above whereas other specimens were used only for the
measurement of mRNA. Immediately on obtaining fresh
tissue from surgery, slices of meniscus or articular cartilage
(approximately 100 mg wet weight) were transferred to
500 l of solution D extraction reagent, [4 M guanidinium
isothiocyanate/25 mM sodium citrate (pH 7.0) contain-
ing 0.5% (w/v) N-lauroylsarcosine (sarcosyl)/0.1 M 2-
mercaptoethanol] immediately after dissection. The tissue
was incubated on ice for 5 min and then either stored at
−70°C or used immediately for RNA extraction. Total RNA
was isolated using the Qiagen RNeasy kit (Qiagen, U.K.)
following the recommended protocol. RNA was eluted in
diethylpyrocarbonate (DEPC)-treated water (1 l per mg
wet weight of original tissue) and stored in aliquots at
−70°C.articular cartilage,20 but there have been very few similar
studies of the human meniscus. An investigation carried out
by Ingman and co-workers21 showed that the concentration
of collagen increased in the meniscus during development.
In addition, McNicol and Roughley14 reported that the
concentration of keratan sulfate increased with age in
human menisci, as did the concentration of the 6-sulfated
disaccharide of chondroitin sulfate.
The composition and biosynthesis of matrix molecules in
the meniscus change during development and maturation.
In this respect they probably reflect an ongoing process of
tissue remodeling, which includes the accumulation of
turnover products during the long period of time that these
molecules are present in the extracellular matrix. There
have been no investigations of the relative rates of turnover
of proteoglycans in the meniscus and articular cartilage and
consequently the extent to which each tissue contributes
turnover products to the synovial fluid milieu is unknown. If
effective use is to be made of the surrogate markers of joint
disease that are currently under investigation in many
laboratories,22 then it is imperative that our understanding
of the biology of the normal meniscus is improved. The
study described in this manuscript is an attempt to address
this deficiency and it provides the first data comparing the
rates of proteoglycan synthesis and gene expression in
human meniscus with that of articular cartilage from the
same knee joint.
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The method described by Bolton et al.28 was used to
prepare decorin competitor RNA templates (Table I).
Briefly, cDNA was synthesized from human chondrocyte
RNA (3 g) using a Moloney Murine Leukemia Virus-
reverse trancriptase (Life Technologies, Renfrewshire,
U.K.). Two overlapping PCRs were carried out using this
cDNA, one using the primer pairs 96/W, 96/R and the other
with the primers 96/Q and 96/X (Table I). cDNA (1 l) was
amplified in a 25 l total reaction mixture with 1 unit
AmpliTaq DNA polymerase (Applied Biosystems, Cheshire,
U.K.) in the recommended buffer conditions, containing
1.6 M each of the appropriate upstream and downstream
primers. After an initial denaturation step at 94°C for 1 min,
amplification was performed at 92°C for 45 s, 52°C for 45 s
and 72°C for 45 s for 30 cycles, with a final 5 min extension
step at 72°C. Products from both PCRs were mixed 1:1,
diluted 100-fold and used in a fresh PCR for 30 cycles
using the primers 96/W and 96/X (Table I). Five cycles were
performed in the absence of primers to encourage overlap
extension. This procedure incorporated an Eco RI site into
the wild-type sequence. Competitor PCR products were
purified and cloned by T/A overlap ligation in pBluescript
KS plasmids. Clones were chosen, after confirming the
nucleotide sequence, from which sense RNA was tran-
scribed with T7 RNA polymerase (Stratagene, Cambridge,
U.K.). Decorin competitor RNA molecules were named
according to the size of the molecule (Dec726). The com-
petitors for aggrecan (Agg219) and GAPDH (GAPDH156)
used were those described by Bolton et al. (1996).28COMPETITIVE RT-PCR
The RT-PCR was carried out using a two-step procedure
with the rTth DNA polymerase kit (Applied Biosystems,
Warrington, Cheshire, U.K.). Briefly, 5 l of sample RNA
was added to 5 l competitor RNA mix containing a known
copy number of decorin, aggrecan and GAPDH competitor
molecules. Final reaction conditions for reverse transcrip-
tion were 10 mM Tris-HCl, pH 8.30, 90 mM KCl, 1 mM
MnCl2, 0.25 mM dNTPs, 20 nM of each reverse primer, 8U
RNA guard and 5 units rTth DNA polymerase in a total
volume of 20 l and these were incubated at 60°C for
30 min. An aliquot of the cDNA (4.5 l) was transferred to a
fresh tube for each specific amplification and was dilutedwith 20 l PCR buffer [containing 10 mM Tris/HCl, pH 8.30,
5% (v/v) glycerol, 100 mM KCl, 0.75 mM EGTA, 0.05%
(v/v) Tween 20, 2.5 mM MgCl2 and 1.6 M each of forward
and reverse primers]. Sequences of forward oligonucle-
otide primers used were: decorin 5′-CACCAAAGTGCGA
AAAGTTAC-3′,29 aggrecan 5′-GGGTCAACAGTGCCTAT
CAG-3′,28 GAPDH 5′-GCATCTTCTTTTGCGTCGCC-3′,28
and reverse primers: decorin 5′-CTTAGCCAAATTATTCA
GTCCTT-3′, aggrecan 5′-GGGTGTAGCGTGTAGAGATG-
3′, and GAPDH 5-GTCATTGATGGCAACAATATCC-3′.
After an initial denaturation at 95°C for 2 min, PCR was
carried out for 30 cycles using a two-step cycling protocol of
denaturation at 93°C for 1 min followed by simultaneous
annealing and extension at 60°C for 1 min. A final exten-
sion step of 7 min at 60°C was carried out. Products were
digested with 5 units of Eco RI, electrophoresed on a 3%
Nusieve (FMC BioProducts, Cambridge, U.K.) agarose gel
and these were detected using ethidium bromide fluor-
escence observed under UV light with a Bio-Rad Gel 1000
system. Gel bands were quantified in the linear range of
fluorescence using Bio-Rad Molecular Analyst software.ResultsTable I
Primer sequences used for the synthesis of decorin competitor RNA templates and for the measurement of
decorin gene expression
Primer name 5′ to 3′ sequence Primer position
96/K CACCAAAGTGCGAAAAGTTAC 567–587
96/L CTTAGCCAAATTATTCAGTCCTT 806–828
96/W ACAACAAAATAACCGAAATCAAAG 350–373
96/X AAAGACTCACACCCGAATAAGAA 1047–1069
96/Q TACATCGAATTCCGCATTGCTGATACCAATATCAC 691–718
96/R AATGCGGAATTCGATGTAGGAGAGCTTCTTCATTC 674–702
Oligonucleotide sequences were located within the published cDNA sequence for human decorin.29 The
oligonucleotide sequences for 96/Q and 96/R and 96/W and 96/X were used for the synthesis of the decorin
competitor RNA templates, and the incorporated Eco RI sequence is shown underlined. Oligonucleotide primers
used in competitive RT-PCR for the measurement of decorin mRNA, 96/K and 96/L (within exons 4 and 6,
respectively) were equidistant from the Eco RI site, present in the competitor sequences. Synthesis of aggrecan
and GAPDH competitors and the primer sequences for gene expression measurement were as described by
Bolton et al.28RATES OF [35S]-SULFATE INCORPORATION
In order to analyze the possible deleterious effects of
in vitro culture on the biosynthesis by fibrochondrocytes, it
was necessary to establish that the rate of proteoglycan
synthesis ([35S]-sulfate incorporation) was linear during the
period of culture. Proteoglycan synthesis by meniscus
explants was linear for up to 6 h of culture (Fig. 1). The
rates of [35S]-sulfate incorporation for all subsequent
studies were, therefore, analyzed after a 4 h culture period.
Tissue slices were taken only from the central region of the
meniscus, because preliminary experiments showed some
variations in synthesis rates between the anterior, central
and posterior region of the tissue (results not shown). The
rates of synthesis did not differ markedly between the
lateral and medial menisci taken from the same specimen
and a similar age-related decrease in synthetic activity was
observed after puberty for both sources of tissue (Fig. 2).
An extensive independent study was carried out in our
laboratory to measure proteoglycan synthesis rates in
aging human articular cartilage.29 Comparing the values
obtained for the meniscus samples in the present study
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Fig. 1. The linearity of sulfate incorporation into meniscus explants
(24-year-old) during 6 h in culture. The rate of [35S]-sulfate incor-
poration into meniscus explants was determined after 2, 3, 4, 5 and
6 h; culture medium (DMEM) containing 50 Ci/ml of isotope.
Rates are expressed as nmoles [35S]-sulfate incorporated/h/g dry
weight. Each value is the average±the standard deviation of
triplicate samples.70
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Fig. 2. Rates of proteoglycan synthesis by explants of lateral and
medial menisci of different ages. [35S]-sulfate incorporation rates
were measured in slices of tissue dissected from the same region
of each meniscus. Explants were radiolabeled for 4 h in DMEM
containing 50 Ci/ml of isotope. Each value represents the aver-
age incorporation rate (nmoles [35S]-sulfate incorporated/h/mg
DNA of tissue) from three tissue slices.with those obtained for age-matched cartilage specimens
of articular cartilage showed that synthesis rates in
cartilage were approximately 10-fold higher than for the
meniscus.electrophoretic pattern to that of newly synthesized proteo-
glycans detected by autoradiography of the same gel. The
newly synthesized proteoglycans (band 1) migrated at the
same position in the gel as aggrecan that was immuno-
localized on Western blots using a polyclonal anti-serum
recognizing the G1-domain of human aggrecan. These
studies confirmed that the meniscus does indeed contain
G1-positive, aggrecan-like structures (Fig. 6). The same
technique was used to show that band 4 was the low
molecular weight, proteoglycan decorin and that band 5
reacted with an anti-serum specific for human biglycan
(results not shown). The electrophoretic patterns of newlyNEWLY SYNTHESIZED PROTEOGLYCANS IN MENISCUS AND
CARTILAGE
Radiolabeled extracts of meniscus were separated
using a two-dimensional fractionation procedure that in-
volved anion-exchange chromatography and agarose-
polyacrylamide gel electrophoresis. A peak corresponding
to newly synthesized [3H]-labeled proteins is identified as
peak I. Newly synthesized proteoglycans are represented
by peak II ([3H]-labeled PG core proteins) and peak III
([35S]-sulfated GAG chains) (Fig. 3). Matrix proteins were
eluted between 0.4 M and 0.8 M NaCl and the negatively
charged proteoglycans were eluted with 1 M NaCl. The
percentage of [3H]-leucine incorporated into the core pro-
tein of proteoglycans [([3H]-dpm in peak II/[3H]-dpm in peak
I)×100] and the extent to which the newly synthesized
proteoglycans were sulfated [([35S]-dpm in peak III/[3H]
dpm in peak II)] was determined for each specimen.
Analysis of medial meniscus and articular cartilage,
obtained from the same knee joint, identified marked differ-
ences in the extent of sulfation of proteoglycans in the two
tissues (Fig. 4).
In general, sulfation of the core protein of newly synthe-
sized proteoglycans increased with age in articular carti-
lage up to the 60-year-old specimen and, in all cases, far
exceeded that measured for the meniscus. In marked
contrast, no age-related trends were identified for the
meniscus. The structure of newly synthesized proteo-
glycans in the meniscus and articular cartilage extracts
were also analyzed by electrophoresis in large pore
agarose polyacrylamide gels (Fig. 5). The endogenous
population of proteoglycans, i.e. those pre-existing in the
tissue (toluidine blue stained gel), gave a very different
Osteoarthritis and Cartilage Vol. 9 No. 1 3730
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Fig. 3. Mono Q anion-exchange chromatography of an extract of
medial meniscus. The dual-labeled ([3H]-leucine and [35S]-sulfate)
extract from a 24-year-old donor was subjected to mono Q
anion exchange chromatography to separate matrix proteins
(peak I) from proteoglycan core protein (peak II) and sulfated
glycosaminoglycans (peak III).0
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Fig. 4. Proteoglycan core protein synthesis and levels of sulfation
of newly synthesized glycosaminoglycan chains by medial menis-
cus and articular cartilage explants of different ages. The pro-
portion of proteoglycan core protein (expressed as a percentage of
total incorporation of [3H]-leucine by the fibrochondrocytes) and
the levels of sulfated glycosaminoglycan chains on these core
proteins were calculated from analysis of mono Q ion-exchange
chromatography fractions (see Methods and Fig. 3).A
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Fig. 5. Endogenous and newly synthesized proteoglycans in the
meniscus following mono Q fractionation. Proteoglycans from
the 24-year-old specimen (Fig. 3) were analyzed by agarose-
polyacrylamide gel electrophoresis followed by staining of the gel
with (A) toluidine blue (endogenous molecules) and (B) autoradio-
graphic analysis (newly synthesized molecules) of the dried
gel. Bands 1–3 represent high molecular weight aggrecan-like
molecules. Bands 4 and 5 indicate the low molecular weight
proteoglycans decorin and biglycan, respectively.Medial meniscus
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Fig. 6. Western blot of the partially purified mono Q ion-exchange
fractions from the medial meniscus of a 17-year-old donor. An
aliquot of each fraction, containing proteoglycans, was electro-
phoresed in agarose-polyacrylamide gels under dissociating con-
ditions and transferred onto nylon membranes. Immunoreactive
bands, i.e. those that reacted with a polyclonal anti-serum raised
against the G1-domain of human aggrecan, were identified using
enhanced chemiluminescence.synthesized proteoglycans, from either the lateral or medial
meniscus, showed that in the youngest specimens the
major biosynthetic product was decorin (Fig. 7). However,
the pattern in the older specimens (34, 40, 57 years) was
different, and intact aggrecan-like molecules (bands 1, 2
and 3) were identified as major biosynthetic components. In
contrast, band 1 was identified as the major biosynthetic
product in articular cartilage at all ages (Fig. 8).and aggrecan were normalized relative to the amount of
GAPDH mRNA in the sample. In the meniscus, there was
an age-related increase in decorin mRNA [Fig. 9(A)], but
not in articular cartilage [Fig. 9(C)] where transcription of
decorin was relatively constant at different ages. The levels
of aggrecan mRNA were also relatively low in the imma-
ture meniscus, but these increased with advancing age
[Fig. 9(B)]. In contrast, no obvious age-related changes
were observed for aggrecan mRNA in articular cartilageDECORIN AND AGGRECAN GENE EXPRESSION
Quantitative, competitive RT-PCR measurements of total
RNA extracted directly from meniscus and cartilage was
carried out for each specimen. Copy numbers of decorin
38 A. McAlinden et al.: Proteoglycans in the human meniscus[Fig. 9(D)]. Interestingly, the levels of decorin mRNA
exceeded that of aggrecan mRNA by 20–300-fold in the
menisci and about 60-fold in the cartilage. Furthermore,
comparison of meniscus and cartilage from the same knee
joint showed that cartilage had higher levels of both aggre-
can mRNA and decorin mRNA than the meniscus (Table II).21Fraction 22 23
– 4
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Fig. 7. Newly synthesized proteoglycans in medial meniscus
extracts of different ages. Proteoglycans from 11, 17, 34, 40 and
57-year-old donors were fractionated on mono Q ion-exchange
columns and then separated by agarose-polyacrylamide gel elec-
trophoresis, under dissociating conditions and visualized by auto-
radiography. Bands 1 and 2 correspond to aggrecan-like structures
and band 4 corresponds to decorin.Articular cartilage, 34 yr
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Fig. 8. Newly synthesized proteoglycans in extracts of articular
cartilage. Proteoglycans from 34 and 40-year-old donors were
separated by agarose-polyacrylamide gel electrophoresis, under
dissociating conditions, and visualized by autoradiography. Band 1
represents the slowest-migrating aggrecan monomer.100
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Fig. 9. Expression of decorin mRNA and aggrecan mRNA in
human medial meniscus and articular cartilage of different ages.
Message levels were expressed relative to GAPDH mRNA in each
sample. Each value represents the average of 4–6 experiments for
each specimen. The relative expression of decorin mRNA (A) and
aggrecan mRNA (B) in the meniscus and decorin mRNA (C) and
aggrecan mRNA (D) in articular cartilage.Discussion
The age-related decrease in proteoglycan synthesis
rates measured for the meniscus confirmed that in the
immature tissue the cells had a high metabolic activity
and in this respect they were like articular chondrocytes.
Decorin and biglycan have been shown to be the
major endogenous proteoglycans present in mature human
meniscus.17 The present study also showed that theseproteoglycans were the major molecular species synthe-
sized by the cells of the immature meniscus. The ability of
decorin to bind to type I collagen fibres30 and control their
fibre diameter highlights the important role it has in stabi-
lizing and organizing the extracellular matrix of the menis-
cus. Decorin also has the ability to bind and sequester
transforming growth factor- (TGF)31 and it may be that
this growth factor has a particularly important role in main-
taining the homeostasis of the meniscus and in promoting
the repair of any damage that may occur during degenera-
tive diseases. Previous studies14,15 showed that an
aggrecan-like molecule was present in the adult meniscus
and in the present study aggrecan-like molecules were also
synthesized by the fibrochondrocytes. Aggrecan was not
detected as part of the endogenous pool of proteoglycans
in the meniscus, presumably because it was not present at
a high enough concentration to be identified by the gel
system we used (Fig. 5). However, they were detected as a
biosynthetic product, especially in mature meniscus. It
seems likely that aggrecan-like molecules are synthesized
at all ages by the fibrochondrocytes, but they constitute a
greater proportion of the total biosynthetic pool of the less
metabolically active, mature fibrochondrocytes. Aggrecan-
like proteoglycans may provide the tissue with the ability to
withstand compressive loads, such as those experienced
by articular chondrocytes. Unpublished data (Dr A.
McAlinden and Professor M. T. Bayliss, in preparation)
investigating the ‘free G1-domain’ of aggrecan in the
meniscus, support this hypothesis. The ‘free G1-domain’ of
aggrecan, generated as a consequence of normal turnover
of aggrecan, accumulates in the meniscus with age as it
does in articular cartilage.29,32,33 The biological mecha-
nism(s) that generate the age-related increase in molecular
heterogeneity in the aggrecan pool are still not fully
resolved. There is substantial evidence to support the
induction of proteolytic enzymes and thus, a catabolic
pathway in their production.34–36 However, more recent
evidence suggests that the toluidine blue-staining bands
identified in the agarose-polyacrylamide gels are, in part,
Osteoarthritis and Cartilage Vol. 9 No. 1 39biosynthetic in origin.29 It seems likely that both mecha-
nisms are responsible for the molecular heterogeneity of
aggrecan and that the fractionation of these proteoglycans
on agarose-polyacrylamide gels is incomplete, i.e. mol-
ecules with a different composition (protein/carbohydrate
ratio) can migrate to the same position on the gel.
Considering that (1) the rate of proteoglycan synthesis
by articular chondrocytes is ∼10-fold greater than that of
meniscus and (2) only the slowest-migrating population of
aggrecan is synthesized by articular chondrocytes, the
metabolic events influencing the synthesis of aggregating
proteoglycans in the meniscus must be very different from
that in articular cartilage. Thus, it cannot be stated with
certainty that the aggrecan-like molecules identified in the
meniscus extracts are identical to those observed in
extracts of articular cartilage, although they may have
similar physicochemical properties.
The differences in the proteoglycans synthesized by
meniscus and cartilage led us to investigate the gene
expression of decorin and aggrecan in these tissues. The
findings presented in this manuscript are the first quantita-
tive analyzes of mRNA expression for RNA extracted
directly from meniscus and articular cartilage explants
obtained from the same knee joint. Published data have
shown that decorin mRNA expression is higher in mature
cartilage than in neonatal cartilage,37,38 but in these
studies RNA was analyzed using either Northern blotting
techniques or a semi-quantitative RT-PCR. In marked con-
trast, our findings did not demonstrate any age-related
change in decorin mRNA expression in articular cartilage.
This may have been a consequence of either the differ-
ences in methodology used (quantitative vs semi-
quantitative RT-PCR), or because neonatal specimens
were not examined in our study. However, we did find a
quantitative increase in the expression of decorin mRNA in
the meniscus. Decorin has a long half-life in the extra-
cellular matrix of human meniscus and articular cartilage39
and the importance of decorin in tissue repair was demon-
strated by van der Kraan and co-workers,40 who showed
that decorin mRNA levels were higher during the process of
matrix restoration after mild proteoglycan depletion. Thus,
an increase in decorin mRNA expression in the meniscus
may be a normal aging process that provides an immedi-
ately available source of mRNA that can be translated intoprotein during adverse loading that may lead to tissue
damage.
As expected, the expression of aggrecan mRNA was
much greater in articular cartilage than in meniscus. Fur-
thermore, the actual mRNA levels in cartilage did not show
any age-related pattern, which was similar to the findings of
Bolton et al.28,41 In contrast to articular cartilage, the
expression of aggrecan mRNA increased in the meniscus
after puberty. It was recently shown that proteoglycan gene
expression changed in the canine meniscus as a result of
joint immobilization or tissue overload induced by anterior
cruciate ligament transection.42 In particular, aggrecan
mRNA levels increased in the overloaded medial meniscus;
however, no biosynthetic evaluation of the tissue was
carried out. An increase in aggrecan mRNA in the meniscus
should result in an increase in aggrecan protein, which will
contribute to the load-bearing properties of the tissue. It is
of interest, therefore, that in the present study the synthesis
of sulfated proteoglycan in the meniscus was shown to
decrease with age. However, a direct comparison of bio-
synthetic studies with the measurement of mRNA for a
particular protein is often problematic, as the former is a
reflection of a dynamic event (a short radio-labeling period),
whereas the latter reflects a specific time point.
By using biochemical and molecular biology techniques,
the present study has extended our knowledge of age-
related changes in the synthesis and mRNA expression of
the proteoglycans in human meniscus and articular carti-
lage. The extent to which any changes are a response to an
altered mechanical environment and/or chemical milieu
remains to be established. An understanding of the biologi-
cal processes occurring during aging of clinically normal
tissue helps us to interpret the changes that may occur as
a consequence of tissue damage or degeneration.Table II
Levels of aggrecan mRNA and decorin mRNA in human meniscus and articular cartilage
Age (years) Aggrecan mRNA/GAPDH mRNA Decorin mRNA/GAPDH mRNA
Meniscus Cartilage Meniscus Cartilage
8 0.013 0.432 0.574 0.400
13 0.014 0.227 1.481 6.831
15 0.014 0.654 0.931 9.601
20 0.011 3.696 0.153 7.243
21 0.013 0.295 0.616 9.327
29 0.047 n.d. 0.231 3.274
34 0.002 5.092 8.174 12.241
53 0.006 2.867 1.587 5.894
57 0.078 1.690 8.085 5.141
60 0.034 2.508 4.599 7.369
66 0.046 0.171 6.483 7.412
71 0.162 0.318 11.406 20.465
Meniscus and cartilage samples were obtained from the same knee joint. For each sample decorin and
aggrecan mRNA levels were measured using competitive RT-PCR and were normalized to that of GAPDH.
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